Stephen Mahoney
2019 - Kiniksa Pharmaceuticals, Ltd.
In 2019, Stephen Mahoney earned a total compensation of $2.7M as Former President and Chief Operating Officer at Kiniksa Pharmaceuticals, Ltd., a 1% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,547,059 |
|---|---|
| Salary | $477,641 |
| Other | $720,279 |
| Total | $2,744,979 |
Mahoney received $1.5M in option awards, accounting for 56% of the total pay in 2019.
Mahoney also received $477.6K in salary and $720.3K in other compensation.
Rankings
In 2019, Stephen Mahoney's compensation ranked 4,448th out of 13,971 executives tracked by ExecPay. In other words, Mahoney earned more than 68.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,448 out of 13,971 | 68th |
Division Manufacturing | 1,648 out of 5,701 | 71st |
Major group Chemicals And Allied Products | 580 out of 2,200 | 74th |
Industry group Drugs | 487 out of 1,886 | 74th |
Industry Pharmaceutical Preparations | 368 out of 1,398 | 74th |
Source: SEC filing on April 28, 2020.
Mahoney's colleagues
We found three more compensation records of executives who worked with Stephen Mahoney at Kiniksa Pharmaceuticals, Ltd. in 2019.
News
Signal Genetics CEO Scott Myers receives $36M in 2023
April 26, 2024
Dianthus Therapeutics Former President, Chief Financial and Operating Officer Stephen Mahoney's 2023 pay jumps 48% to $1.7M
April 11, 2024
Kiniksa Pharmaceuticals, Ltd. CEO Sanj Patel's 2019 pay falls 35% to $4.8M
April 28, 2020
Kiniksa Pharmaceuticals, Ltd. CEO Sanj Patel's 2018 pay jumps 389% to $7.3M
April 17, 2019